Article info

Download PDFPDF
Original research
Newborn screening for spinal muscular atrophy with disease-modifying therapies: a cost-effectiveness analysis

Authors

  • Sophy TF Shih Kirby Institute, University of New South Wales, Sydney, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Michelle Anne Farrar Neurology, Sydney Children's Hospital Network, Randwick, New South Wales, Australia School of Women's and Children's Health, UNSW Medicine, University of New South Wales, Sydney, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Veronica Wiley NSW Newborn Screening Programme, Children's Hospital at Westmead, Westmead, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Georgina Chambers School of Women's and Children's Health, UNSW Medicine, University of New South Wales, Sydney, New South Wales, Australia Centre for Big Data Research in Health, University of New South Wales, Sydney, New South Wales, Australia PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Sophy TF Shih, Kirby Institute, University of New South Wales, Sydney, New South Wales, Australia; sshih{at}kirby.unsw.edu.au
View Full Text

Citation

Shih ST, Farrar MA, Wiley V, et al
Newborn screening for spinal muscular atrophy with disease-modifying therapies: a cost-effectiveness analysis

Publication history

  • Received February 9, 2021
  • Accepted June 24, 2021
  • First published July 28, 2021.
Online issue publication 
November 16, 2021

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.